Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Conference Steering Committee

doi:10.1016/j.kint.2018.05.005

Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Conference Steering Committee

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Original language	English (US)
Pages (from-to)	231-234
Number of pages	4
Journal	Kidney international
Volume	94
Issue number	2
DOIs	https://doi.org/10.1016/j.kint.2018.05.005
State	Published - Aug 2018

Funding

CW declared having received consultancy fees from Boehringer Ingelheim, GlaxoSmithKline, and Sanofi Genzyme; speaker honorarium from Boehringer Ingelheim, Merck Sharpe & Dohme, and Sanofi Genzyme; and research support from Sanofi Genzyme. CAH declared having received consultancy fees from AbbVie, FibroGen, KBP Biosciences, OxThera, and Relypsa; equity ownership/stock options on Boston Scientific, Bristol-Myers Squibb, General Electric, Johnson & Johnson, and Merck; and research support from Amgen, National Institutes of Health, Relypsa, and Zoll. CAH also expects future consultancy roles from AstraZeneca, Boehringer Ingelheim, Corvidia, and Sanifit. MPT declared having received consultancy fees from Abbott, iBeat, iRhythm, Medtronic, and Precision Health Economics; equity ownership/stock options on AliveCor and iBeat; speaker honorarium from Abbott and Medtronic; and research support from American Heart Association, Apple, Cardiva Medical, and Veterans Health Administration.

Keywords

arrhythmia
atrial fibrillation
chronic kidney disease
stroke
sudden cardiac death

ASJC Scopus subject areas

Nephrology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.kint.2018.05.005

Cite this

@article{4f79030b9aef481e91e2905a64e4b69e,

title = "Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference",

keywords = "arrhythmia, atrial fibrillation, chronic kidney disease, stroke, sudden cardiac death",

author = "{Conference Steering Committee} and Christoph Wanner and Herzog, {Charles A.} and Turakhia, {Mintu P.} and Blankestijn, {Peter J.} and Carrero, {Juan Jesus} and Clase, {Catherine M.} and Rajat Deo and Kasner, {Scott E.} and Passman, {Rod S.} and Roberto Pecoits-Filho and Holger Reinecke and Shroff, {Gautam R.} and Wojciech Zareba and Michael Cheung and Wheeler, {David C.} and Winkelmayer, {Wolfgang C.}",

note = "Funding Information: CW declared having received consultancy fees from Boehringer Ingelheim, GlaxoSmithKline, and Sanofi Genzyme; speaker honorarium from Boehringer Ingelheim, Merck Sharpe & Dohme, and Sanofi Genzyme; and research support from Sanofi Genzyme. CAH declared having received consultancy fees from AbbVie, FibroGen, KBP Biosciences, OxThera, and Relypsa; equity ownership/stock options on Boston Scientific, Bristol-Myers Squibb, General Electric, Johnson & Johnson, and Merck; and research support from Amgen, National Institutes of Health, Relypsa, and Zoll. CAH also expects future consultancy roles from AstraZeneca, Boehringer Ingelheim, Corvidia, and Sanifit. MPT declared having received consultancy fees from Abbott, iBeat, iRhythm, Medtronic, and Precision Health Economics; equity ownership/stock options on AliveCor and iBeat; speaker honorarium from Abbott and Medtronic; and research support from American Heart Association, Apple, Cardiva Medical, and Veterans Health Administration. ",

year = "2018",

month = aug,

doi = "10.1016/j.kint.2018.05.005",

language = "English (US)",

volume = "94",

pages = "231--234",

journal = "Kidney international",

issn = "0085-2538",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Chronic kidney disease and arrhythmias

T2 - highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

AU - Conference Steering Committee

AU - Wanner, Christoph

AU - Herzog, Charles A.

AU - Turakhia, Mintu P.

AU - Blankestijn, Peter J.

AU - Carrero, Juan Jesus

AU - Clase, Catherine M.

AU - Deo, Rajat

AU - Kasner, Scott E.

AU - Passman, Rod S.

AU - Pecoits-Filho, Roberto

AU - Reinecke, Holger

AU - Shroff, Gautam R.

AU - Zareba, Wojciech

AU - Cheung, Michael

AU - Wheeler, David C.

AU - Winkelmayer, Wolfgang C.

N1 - Funding Information: CW declared having received consultancy fees from Boehringer Ingelheim, GlaxoSmithKline, and Sanofi Genzyme; speaker honorarium from Boehringer Ingelheim, Merck Sharpe & Dohme, and Sanofi Genzyme; and research support from Sanofi Genzyme. CAH declared having received consultancy fees from AbbVie, FibroGen, KBP Biosciences, OxThera, and Relypsa; equity ownership/stock options on Boston Scientific, Bristol-Myers Squibb, General Electric, Johnson & Johnson, and Merck; and research support from Amgen, National Institutes of Health, Relypsa, and Zoll. CAH also expects future consultancy roles from AstraZeneca, Boehringer Ingelheim, Corvidia, and Sanifit. MPT declared having received consultancy fees from Abbott, iBeat, iRhythm, Medtronic, and Precision Health Economics; equity ownership/stock options on AliveCor and iBeat; speaker honorarium from Abbott and Medtronic; and research support from American Heart Association, Apple, Cardiva Medical, and Veterans Health Administration.

PY - 2018/8

Y1 - 2018/8

KW - arrhythmia

KW - atrial fibrillation

KW - chronic kidney disease

KW - stroke

KW - sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=85048710439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048710439&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2018.05.005

DO - 10.1016/j.kint.2018.05.005

M3 - Article

C2 - 29935952

AN - SCOPUS:85048710439

SN - 0085-2538

VL - 94

SP - 231

EP - 234

JO - Kidney international

JF - Kidney international

IS - 2

ER -

Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this